Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2007-11-14 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Regulatory Filings Classification · 95% confidence The document is a short regulatory filing dated 14/11/2007 from XTL BIOPHARMACEUTICALS LTD. It explicitly states under 'Other Report or Announcement' that it is attaching a report titled 'Letter regarding the Shareholders’ Choices Following De-Listing of the Company's Ordinary Shares from the London Stock Exchange (LSE)'. Since the document itself is an announcement about an attached letter/report concerning a corporate action (de-listing), and it is very short (1720 chars), it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of the content (a letter to shareholders about de-listing), it is a specific regulatory communication. However, the core function here is announcing the publication of a specific document ('Letter regarding the Shareholders’ Choices'). If the content of the letter itself were present, it might fit LTR (Legal/Regulatory Action) or SHA (Share Change), but as an announcement of the letter, RPA is appropriate. Since the content is a formal communication regarding a significant corporate event (de-listing), and it is not a standard 10-K, IR, or ER, RNS (Regulatory Filings - fallback for miscellaneous specific announcements) is also a strong candidate. Given the context of de-listing and shareholder communication, and the structure being an announcement of an attached document, RNS is the most appropriate general regulatory category for this specific type of notice that doesn't fit the other specific codes like DIV, SHA, or DLST (which is usually the formal notice of delisting, not the follow-up letter). I will classify it as RNS as it is a general regulatory announcement regarding a specific corporate event outcome.
2007-11-14 English
Immediate Report
Regulatory Filings
2007-11-14 Hebrew (modern)
Immediate Report
Regulatory Filings Classification · 95% confidence The document is an 'Immediate Report' filed by a foreign corporation (T L BIOPHARMACEUTICALS LTD) with the Israel Securities Authority and the Tel Aviv Stock Exchange. The core content states: 'Attached hereto is a report on *Company filed an amended registration statement on form F-3 with the Securities and Exchange Commission.*' and references a PDF file ('131107F3_isa.pdf'). This structure—a brief announcement stating that a specific regulatory filing (Form F-3, which is a registration statement) has been submitted to the SEC and is attached or referenced—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the document itself is not the F-3 registration statement but an announcement *about* it, and given the specific nature of announcing a filing action, RPA is a strong candidate, but RNS is the general fallback for regulatory announcements not covered elsewhere. Form F-3 is a registration statement, which is a type of regulatory filing. Given the context of announcing a filing action to the local exchange, and the short length (Rule 2 applies), RNS (Regulatory Filings) is the most appropriate general category for this type of immediate regulatory disclosure that isn't a standard periodic report or specific event notice like a dividend or AGM.
2007-11-14 English
Delisting Announcement 2007
Delisting Announcement Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. The content focuses on informing shareholders about the delisting of the company's ordinary shares from the London Stock Exchange (LSE) following a vote at an Extraordinary General Meeting. It provides details on shareholders' options post-delisting, including holding shares, converting to ADRs traded on NASDAQ, or trading on the Tel Aviv Stock Exchange. The document is essentially an official notice regarding the delisting event and subsequent shareholder instructions. There are no financial statements, audit information, or earnings data presented. The primary subject is the delisting announcement and related shareholder information, which fits the definition of a Delisting Announcement (DLST). The document length is about 4908 characters, which is sufficient to be the announcement itself rather than a brief report publication notice. Therefore, the correct classification is DLST with high confidence.
2007-11-13 English
Capital/Financing Update 2007
Capital/Financing Update Classification · 95% confidence The document is a Form F-3/A Registration Statement Amendment No. 1 filed with the SEC by XTL Biopharmaceuticals Ltd. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes details about the securities being registered, the offering, selling shareholders, and related legal and financial information. It is not a financial report, earnings release, or management discussion, but a capital markets filing related to securities registration and offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2007-11-13 English
Regulatory Filings 2007
Regulatory Filings
2007-11-09 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.